[Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D001856:Bone Marrow Examination; D004273:DNA, Neoplasm / Q000032:analysis; D004357:Drug Synergism; D004950:Esterases / Q000097:blood; D005069:Evaluation Studies as Topic; D005260:Female; D005826:Genetics, Medical; D006651:Histocytochemistry; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000145:classification / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D010544:Peroxidases / Q000097:blood; D010783:Photometry; D011123:Polyploidy; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D013194:Staining and Labeling; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D014750:Vincristine; D015122:Mercaptopurine; D010544:Peroxidases; D004950:Esterases; D011241:Prednisone
Klinisch-pharmakologische, cytochemische und Feulgen-photometrische Untersuchungen bei unreifzelligen Erwachsenenleukosen unter kombinierter Chemotherapie mit Vincristin, Daunorubicin und Prednison.